The 20 Best Percutaneous Coronary Intervention (PCI) Doctors in Maryland, US

Paul Gurbel is a Cardiologist in Baltimore, Maryland. Dr. Gurbel is rated as a Distinguished provider by MediFind in Percutaneous Coronary Intervention (PCI). His top areas of expertise are Acute Coronary Syndrome, Coronary Heart Disease, Heart Attack, Percutaneous Coronary Intervention (PCI), and Angioplasty.

Paul Armstrong is a Family Medicine provider in Forest Hill, Maryland. Dr. Armstrong is rated as a Distinguished provider by MediFind in Percutaneous Coronary Intervention (PCI). His top areas of expertise are Acute Coronary Syndrome, Heart Attack, Heart Failure, Percutaneous Coronary Intervention (PCI), and Angioplasty.

Brian Case is an Interventional Cardiologist in Clinton, Maryland. Dr. Case is rated as a Distinguished provider by MediFind in Percutaneous Coronary Intervention (PCI). His top areas of expertise are Heart Attack, Coronary Heart Disease, Stable Angina, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Gabriel L. Sardi, MD, specializes in cardiology and is board-certified in internal medicine and interventional cardiology by the American Board of Internal Medicine. Dr. Sardi completed his fellowship at Lehigh Valley Health Network, residency at Albert Einstein Medical Center and medical degree at Universidad de Los Andes. Dr. Sardi is rated as an Advanced provider by MediFind in Percutaneous Coronary Intervention (PCI). His top areas of expertise are Heart Attack, Apoplexy, Coronary Heart Disease, Percutaneous Coronary Intervention (PCI), and Angioplasty.

Aloke Finn is a Cardiologist in Rockville,, Maryland. Dr. Finn is rated as an Advanced provider by MediFind in Percutaneous Coronary Intervention (PCI). His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Heart Attack, Angioplasty, and Percutaneous Coronary Intervention (PCI).

Sara Collins is a Cardiologist in Bowie,, Maryland. Dr. Collins is rated as an Advanced provider by MediFind in Percutaneous Coronary Intervention (PCI). Her top areas of expertise are Heart Attack, Aortic Valve Stenosis, Acute Coronary Syndrome, Percutaneous Coronary Intervention (PCI), and Transcatheter Aortic Valve Replacement (TAVR).

Jon R. Resar received his M.D. from the Medical College of Wisconsin in 1985. He completed an internal medicine residency at The Johns Hopkins Hospital and fellowships in cardiovascular medicine and interventional cardiology at The Johns Hopkins Hospital and Johns Hopkins University School of Medicine. He joined the faculty at Johns Hopkins in 1992 and is currently a Professor of Medicine/Cardiology. He was the past Director of the Adult Catheterization Laboratory and Interventional Cardiology at the Johns Hopkins Hospital. His field of specialization is management of coronary artery disease and valvular heart disease. Dr. Resar holds memberships in the American Heart Association and is a Fellow of the American College of Cardiology. Dr. Resar is rated as an Experienced provider by MediFind in Percutaneous Coronary Intervention (PCI). His top areas of expertise are Aortic Valve Stenosis, Heart Attack, Patent Foramen Ovale, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Erin D. Michos is a Professor of Medicine within the Division of Cardiology at Johns Hopkins School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Women's Cardiovascular Health and the Associate Director of Preventive Cardiology within the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. Dr. Michos is an internationally known expert in Preventive Cardiology and Women’s Health, having authored >700 publications and 11 book chapters. Her research involves (1) Women’s Cardiovascular Health; (2) Lipids and Lipid management; (3) Cardio-Kidney-Metabolic and Obesity disease management (4) Coronary artery calcium, inflammation and biomarkers of cardiovascular risk. She is the co-Editor-in-Chief for the American Journal of Preventive Cardiology. She is Co-Director of the IMPACT Center (Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials) at Johns Hopkins, funded by the American Heart Association (AHA). She is a co-investigator in several NIH-funded studies including the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities cohorts. She has served as the Training Director for four AHA Strategic Focused Research Networks. She has mentored over 60 individuals and the recipient of 2 mentoring awards. Additionally, she was the recipient of the Nanette Wegner Award for Women’s Health Medical Leadership by the Women Heart Organization and the Donna Vogel Women’s Health Champion Award by Johns Hopkins University. Dr. Michos completed medical school at Northwestern University, Internal Medicine residency and Cardiology fellowship at the Johns Hopkins Hospital, and a Masters of Health Science degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Michos is rated as an Experienced provider by MediFind in Percutaneous Coronary Intervention (PCI). Her top areas of expertise are Atherosclerosis, Vitamin D Deficiency, Heart Failure, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Jennifer S. Lawton, M.D., is the Richard Bennett Darnall Professor of Surgery and chief of the Johns Hopkins Division of Cardiac Surgery, as well as director of the Cardiac Surgery Research Laboratory. Dr. Lawton’s clinical area of focus is adult cardiac surgery. She also leads the division’s residency education program, and conduct research in myocyte volume regulation and ATP-sensitive K channels. She has held important leadership roles in several organizations, including chair of the surgery study section of the American Heart Association, vice-chair of the ACGME residency review committee, and president of the Women in Thoracic Surgery. Lawton’s achievements also include 81 peer-review publications, 7 book chapters, and 18 abstracts. She has delivered over 50 invited lectures. Dr. Lawton is rated as an Experienced provider by MediFind in Percutaneous Coronary Intervention (PCI). Her top areas of expertise are Heart Tumor, Aortic Dissection, Atrial Myxoma, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG).

Rani Hasan is an Interventional Cardiologist in Baltimore, Maryland. Dr. Hasan is rated as an Experienced provider by MediFind in Percutaneous Coronary Intervention (PCI). His top areas of expertise are Aortic Valve Stenosis, Apoplexy, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Peter Libby is a Neuroradiologist in Salisbury, Maryland. Dr. Libby is rated as an Experienced provider by MediFind in Percutaneous Coronary Intervention (PCI). His top areas of expertise are Stroke, Bronchogenic Cyst, Gallbladder Disease, Bone Graft, and Vertebroplasty.

Dr. Johnston joined the Cardiology Faculty in 2008 and currently practices Interventional Cardiology at Johns Hopkins Hospital, Bayview Medical Center, and Johns Hopkins Howard County Medical Center. His primary research interest is in novel therapies for heart failure and he is involved in both clinical trials and pre-clinical studies currently underway at Johns Hopkins. Dr. Johnston is rated as an Experienced provider by MediFind in Percutaneous Coronary Intervention (PCI). His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Bone Marrow Aspiration, and Percutaneous Coronary Intervention (PCI).

Dr. Gary Gerstenblith is professor of medicine and director of clinical trials in the Johns Hopkins Medicine Division of Cardiology. He also serves as attending physician in r the Cardiology care Unit. Dr. Gerstenblith earned his undergraduate degree from New York University and his medical degree from the University of Pennsylvania School of Medicine. After working at the National Institute on Aging and the National Institutes of Health (NIH) and completing a fellowship at Jackson Memorial Hospital in Miami, Dr. Gerstenblith joined the faculty of the Johns Hopkins University School of Medicine. Dr. Gerstenblith conducts clinical trials in patients with cardiovascular disease. His research interests include the impact of cardiovascular aging on cardiac structure and function, and the use of stem cells to repair damaged cardiac muscle. He has published nearly 250 articles and book chapters and has been a referee for numerous journals including Circulation, The New England Journal of Medicine and The Journal of the American College of Cardiology. Dr. Gerstenblith is rated as an Experienced provider by MediFind in Percutaneous Coronary Intervention (PCI). His top areas of expertise are Heart Attack, Atherosclerosis, Coronary Heart Disease, Apoplexy, and Percutaneous Coronary Intervention (PCI).

Dr. Thomas R. Aversano is an associate professor of medicine at Johns Hopkins University. He is also the associate chief of cardiology at Johns Hopkins Cardiology at GBMC and the director of the Atlantic Cardiovascular Patient Outcomes Research Team (C-PORT). His research interests focus on health services research - public policy, cardiovascular disease treatment, coronary intervention, and patient outcomes research in cardiovascular disease. Dr. Aversano received an undergraduate degree from the University of Rochester and a medical degree from the University of Oklahoma. He was a resident of internal medicine as well as a research fellow in cardiology at S.U.N.Y. at Buffalo before joining Johns Hopkins University as a cardiology fellow in 1982. Dr. Aversano has contributed to Johns Hopkins InHealth, specifically the development of a cardiology program (inCar) within the InHealth initiative focused on creation of a real-time decision-support, communication, and documentation tool for interventional cardiology. He also created and leads the Atlantic Cardiovascular Patient Outcomes Research Team (C-PORT) whose projects have involved 87 hospitals in 11 States and recruited more than 30,000 patients in randomized trials and registries. C-PORT worked with Departments of Health in 13 States to perform these studies. These projects were instrumental in changing both national heart association guidelines and State health care policy regarding performance of percutaneous coronary intervention (PCI). Dr. Aversano is rated as an Experienced provider by MediFind in Percutaneous Coronary Intervention (PCI). His top areas of expertise are Familial Ventricular Tachycardia, Transient Ischemic Attack (TIA), Inappropriate Sinus Tachycardia (IST), Arrhythmias, and Percutaneous Coronary Intervention (PCI).

Dr. Michael J. Blaha MD MPH is Professor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Director of the Cardiometabolic Clinic, and Program Director for the Preventive Cardiology Fellowship. His clinical interests include primary and secondary prevention of cardiovascular disease, with emphasis on early intervention in patients with advanced subclinical atherosclerosis detected with cardiac computed tomography. Dr. Blaha represents the 4th generation of physicians in his family. After earning a BS in pre-medical studies and classical civilization at the University of Notre Dame in 2001, Dr. Blaha went to Vanderbilt University where in 2006 he received his MD as well as an MPH. in clinical epidemiology and biostatistics. Dr. Blaha then completed his Internal Medicine residency in the Osler Medical Housestaff Training Program at Johns Hopkins in 2009 before completing a fellowship in Cardiology at Johns Hopkins in 2012. In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring. He has mentored over 30 trainees, many of which have gone on to hold prominent academic appointments. In 2021, Dr. Blaha was named to the Clarivate Highly Cited Researcher List, representing the top 1% of world’s researchers, and was first named to the Baltimore Magazine Best Doctors List. In 2022, he received the Arthur S. Agatston Cardiovascular Disease Prevention Award. Clinically, he practices as a preventive cardiologist specializing in cardiometabolic disease and in the interpretation of cardiac CT. His clinic specializes in patients with cardiometabolic disease and advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk. Dr. Blaha is rated as an Experienced provider by MediFind in Percutaneous Coronary Intervention (PCI). His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, Metabolic Syndrome, and Percutaneous Coronary Intervention (PCI).

"Originally from Wisconsin, Dr. Czarny attended the University of Wisconsin where he majored in molecular biology. After medical school at the Johns Hopkins University School of Medicine, he completed an internal medicine residency at the Brigham and Women’s Hospital in Boston followed by cardiovascular disease, interventional cardiology, and structural heart disease fellowships at Johns Hopkins. Currently, he is a faculty member in interventional cardiology and performs heart catheterizations and coronary artery stenting for patients with stable coronary artery disease (CAD) and myocardial infarctions (""heart attacks"") at both the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center. He is also a member of the Structural Heart Disease team and performs minimally invasive, catheter-based treatments for structural heart disease at the Johns Hopkins Hospital including transcatheter aortic valve replacement (TAVR) for aortic valve stenosis, valve repair/replacement procedures for mitral valve regurgitation and stenosis, patent foramen ovale closure, atrial septal defect closure, alcohol septal ablation for hypertrophic cardiomyopathy, and left atrial appendage occlusion with the Watchman(TM) device. He sees patients in his structural heart disease clinics at both the Johns Hopkins Hospital and the Johns Hopkins Bayview Medical Center. Dr. Czarny's research interests include the safety of cardiac stenting at hospitals without cardiac surgery backup and outcomes of catheter-based structural heart procedures.". Dr. Czarny is rated as an Experienced provider by MediFind in Percutaneous Coronary Intervention (PCI). His top areas of expertise are Aortic Valve Stenosis, Apoplexy, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Andrew Farb is a clinical cardiologist with additional training in pathology. He has been with Cardiovascular Specialists, where he practices on a part-time basis, since 1989. He works full-time as chief medical officer in the Office of Cardiovascular Devices for the US Food and Drug Administration. Previously, he was a staff cardiologist and cardiovascular pathologist for the Armed Forces Institute of Pathology. He is a member of the Active physician admitting staff at Johns Hopkins Howard County Medical Center. Dr. Farb is rated as an Experienced provider by MediFind in Percutaneous Coronary Intervention (PCI). His top areas of expertise are Heart Attack, Apoplexy, Peripheral Artery Disease, Angioplasty, and Percutaneous Coronary Intervention (PCI).

Dr. Zadeh is Professor of Medicine at the Johns Hopkins University School of Medicine and Director of Cardiac Computed Tomography in the Division of Cardiology at the Johns Hopkins Hospital in Baltimore, MD. After attending medical school in Germany and completing internships in medicine and surgery in Germany and Britain, he spent several years in cardiovascular research at the University of California at San Diego to study coronary artery disease using intravascular ultrasound. He then completed his postgraduate training in Philadelphia and Dallas to join the cardiology faculty at Johns Hopkins Hospital after a CT imaging fellowship in 2005. Dr. Zadeh directs the CT coronary angiography core laboratory for the CorE-320 multicenter trial and is member of its steering committee. He is also co-director of the SCCT Board Review Course and editor of the SCCT Board Review Preparation Book. Dr. Zadeh's particular clinical and investigational focus is the pursuit of strategies to better identify patients at risk for future cardiac events using cardiac imaging. He reviews manuscripts for numerous scientific journals, including JACC, JACCimaging, JCCT, AJR, Heart, AJC, and is an author of articles in Circulation, New England Journal of Medicine, JACC, AHJ, and others. Dr. Arbab is rated as an Experienced provider by MediFind in Percutaneous Coronary Intervention (PCI). His top areas of expertise are Coronary Heart Disease, Heart Attack, Atherosclerosis, Heart Bypass Surgery, and Percutaneous Coronary Intervention (PCI).

Roger Blumenthal is the Kenneth Jay Pollin Professor of Cardiology, professor of medicine and director of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease in Baltimore, Maryland. His principal clinical and research interests involve: 1) strategies to improve cardiovascular risk assessment to identify those adults at elevated risk and those at very low risk of cardiovascular disease and 2) the optimal management of atherosclerotic vascular disease. He is an expert in the pathogenesis, treatment and prevention of atherosclerotic vascular disease. Dr. Blumenthal was the principal developer of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. He is on the official national spokesperson panel for the American Heart Association and has co-written more than 600 articles dealing with many aspects of coronary heart disease and atherosclerosis management. An experienced writer, Dr. Blumenthal is on the editorial board of Circulation, Cardiology Today, and The American College of Cardiology and Extended Learning Center. He is a fellow of the American College of Cardiology and the American Heart Association’s Epidemiology and Prevention Council. He was co-editor-in-chief of the textbook Preventive Cardiology – A Companion to Braunwald’s Heart Disease. He received his medical degree from Cornell Medical College, where he was awarded the Weiss Prize for Excellence in Clinical Medicine. He did his internal medicine and cardiology fellowship training at The Johns Hopkins Hospital before joining the Johns Hopkins cardiology faculty. Dr. Blumenthal was the 2019 recipient of the Landon School Anthony Kupka Distinguished Alumnus Award. He was co-chairperson of the 2019 American College of Cardiology/American Heart Guideline on prevention of cardiovascular disease. Dr. Blumenthal is rated as an Experienced provider by MediFind in Percutaneous Coronary Intervention (PCI). His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Metabolic Syndrome, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Dr. Chao-Wei Hwang is an interventional cardiologist and Assistant Professor of Medicine at Johns Hopkins. Dr. Hwang received doctoral and medical training at Harvard Medical School. He completed residency in Internal Medicine at Brigham and Women's Hospital, and Cardiology and Interventional Cardiology fellowships at The Johns Hopkins Hospital. Dr. Hwang joined the Division of Cardiology as faculty in 2011. He spent a year at Virtua Health System in New Jersey as systemwide Director of Interventional Cardiology, and is now Director of the Johns Hopkins Interventional Cardiology Program at Frederick Health Hospital (FHH) and Co-Medical Director of the FHH Cardiac Catheterization Lab. Dr. Hwang is an expert interventional cardiologist specializing in complex coronary interventions, management of acute coronary syndromes and advanced coronary artery disease. He has specialized expertise in PCI of chronic total occlusions (CTO). Dr. Hwang has been involved in a number of device and coronary clinical trials, and his broad areas of research interests include developing and optimizing devices for the treatment of coronary artery disease. Dr. Hwang has published extensively in stent-based drug delivery systems and local delivery systems for cell-based therapies to the heart. Dr. Hwang is rated as an Experienced provider by MediFind in Percutaneous Coronary Intervention (PCI). His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Angioplasty, and Percutaneous Coronary Intervention (PCI).